Chinese guideline for diagnosis and treatment of autoimmune pancreatitis(Shanghai,2023)

VernacularTitle:中国自身免疫性胰腺炎诊治指南(上海,2023)
Author: National Clinical Research Center for Digestive Diseases(Shanghai) ; National Key Laboratory of Immunity and Inflammation ; Professional Committee of Pancreatic Disease,Chinese Medical Doctor Association ; Pancreas Study Group,Society of Gastroenterology,Chinese Medical Association ; Editorial Board of Chinese Journal of Pancreatology ; Zhaoshen LI ; Xun LI ; Xiaozhong GUO ; Zhuan LIAO
Keywords: Autoimmune Pancreatitis; IgG4-related Disease; Guideline; Multidisciplinary Diagnosis and Treatment
From: Journal of Clinical Hepatology 2024;40(7):1312-1320
CountryChina
Language:Chinese
Abstract: Autoimmune pancreatitis(AIP)is an immune-mediated,special type of chronic pancreatitis,which can involve multiple organs.The clinical manifestation of AIP is complex and varied,making the diagnosis and treatment challenging.With reference to the latest guidelines and studies from both domestic and international sources,this guideline comprises 20 recommendations regarding the diagnosis,treatment,follow-up,and prognosis of AIP.The aim of this guideline is to promote the care capability and improve the outcome of patients with AIP in China.